Dr. Jonathan Goldman has contributed to 3 publications.
Effect of Food on the Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) in Patients with Advanced Solid Tumors.
Falchook, G. S.,Zhou, X.,Venkatakrishnan, K.,Kurzrock, R.,Mahalingam, D.,Goldman, J. W.,Jung, J.,Ullmann, C. D.,Milch, C.,Rosen, L. S.,Sarantopoulos, J.; Drugs R D. 2015 Dec 23.
See more >>
Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.
Bendell, J. C.,Rosen, L. S.,Mayer, R. J.,Goldman, J. W.,Infante, J. R.,Benedetti, F.,Lin, D.,Mizuguchi, H.,Zergebel, C.,Patel, M. R.; Cancer Chemother. Pharmacol.. 2015 Nov 22.
See more >>
Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.
Bendell, J. C.,Rosen, L. S.,Mayer, R. J.,Goldman, J. W.,Infante, J. R.,Benedetti, F.,Lin, D.,Mizuguchi, H.,Zergebel, C.,Patel, M. R.; Cancer Chemother. Pharmacol.. 2015 Sep 16.
See more >>
Hospitals & Clinics
specialties & services
